Related Experiment Video

Updated: May 10, 2026

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
06:23

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells

Published on: November 21, 2025

TIMP2 and TIMP3 have divergent roles in early renal tubulointerstitial injury

Zuocheng Wang1, Konrad Famulski2, Jiwon Lee3

  • 11] Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada [2] Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.

Kidney International
|June 14, 2013
PubMed

Insights

Tissue inhibitors of metalloproteinases (TIMPs) play contrasting roles in kidney injury. TIMP3 protects against renal damage, while TIMP2 exacerbates injury by promoting MMP2 activation.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Biochemistry

Background:

  • Tissue inhibitors of metalloproteinases (TIMPs) regulate matrix metalloproteinases (MMPs).
  • TIMP2 and TIMP3 have distinct effects on MMP activity and pro-MMP2 activation.
  • The specific roles of TIMP2 and TIMP3 in renal injury remain to be fully elucidated.

Purpose of the Study:

  • To investigate the differential roles of TIMP2 and TIMP3 in renal injury using a unilateral ureteral obstruction model.
  • To compare the effects of TIMP3 deficiency versus TIMP2 deficiency on kidney gene expression and pathological pathways.

Main Methods:

  • Utilized a unilateral ureteral obstruction mouse model.
  • Performed gene microarray assays to assess global gene expression changes.
  • Analyzed collagen expression, fibrotic markers, and key signaling pathways (Smad2/3, TNF-α, caspase-3, MAPK).
  • Measured matrix metalloproteinase-2 (MMP2) activation.

Main Results:

  • TIMP3 deficiency significantly impacted injury- and repair-related gene expression.
  • Renal injury in TIMP3(-/-) mice showed increased collagen, CTGF, TGF-β, and Smad2/3 pathway activation.
  • TIMP3(-/-) kidneys exhibited elevated MMP2 activation, caspase-3, and MAPK activity, indicating enhanced apoptosis and pathology.
  • TIMP2(-/-) kidneys showed reduced fibrosis and blocked MMP2 activation during obstruction.

Conclusions:

  • TIMP3 plays a protective role in renal injury, mitigating fibrosis and apoptosis.
  • TIMP2 promotes renal injury, partly through the activation of MMP2.
  • TIMP2 and TIMP3 exhibit opposing functions in the context of kidney damage and repair.

More Related Videos

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Renal Tubule and Collecting Duct01:24

Renal Tubule and Collecting Duct

The renal tubule is divided into three parts: the proximal convoluted tubule (PCT), the Loop of Henle (LOH), and the distal convoluted tubule (DCT).
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...